Image (D6623a49 00d9 4081 B73f 338c61f4de4b 01)
Avopef Injection
Product Images NDC 83831-144
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Avopef (NDC 83831-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Avopef-carton- 20mg/ml (D6623a49 00d9 4081 B73f 338c61f4de4b 02)
This is information about a medication called Etoposide, presented in a sterile solution for intravenous infusion after dilution. The composition includes 20 mg of etoposide, dehydrated alcohol, polyethylene glycol, and polysorbate 80. It is recommended to store between 20°C to 25°C and discard any partially used vial after 28 days. The product is marked as a hazardous drug and manufactured by Avyxa Pharma in the USA. The container closure does not contain natural rubber latex. The recommended dosage and further details can be found in the prescribing information.*
Avopef-vial- 20mg/ml (D6623a49 00d9 4081 B73f 338c61f4de4b 03)
Image (Da4c9853 21d9 4024 8c44 303fc2b701be 111 1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
